S177: JAK INHIBITION AND COMBINATION THERAPY IN THE TREATMENT OF MURINE BONE MARROW FAILURE

HemaSphere (Aug 2023)

Affiliations

Xingmin Feng: 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
Jibran Durrani: 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
Ash Lee Manley: 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
Wu Zhijie: 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
Nidhi Aggarwal: 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
Jichun Chen: 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
Emma Groarke: 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States
Young Neal: 1 National Institutes of Health, Hematology Branch/NHLBI, Bethesda, United States

Abstract

No abstracts available.

ISSN: 2572-9241 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.hemaspherejournal.com